Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer

Gynecologic Oncology

Volumn 61, Issue 3, 1996, Pages 403-408

  Santin, Alessandro D ^a,b,c   Hiserodt, John C ^a,b   Disaia, Philip J ^b   Pecorelli, Sergio ^b,c   Granger, Gale A ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Memorial Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GAMMA IRRADIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; OVARY CANCER; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0030008658     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0164     Document Type: Article

References (28)

1. DiSaia, P. J., and Creasman, W. T. Epithelial ovarian cancer, in Clinical Gynecologic Oncology (P. J. DiSaia and W. T. Creasman, Eds.), Mosby-Year Book, St. Louis, MO, pp. 333-425 (1993).
2. Moore, M. Immunity to tumors, in Immunology (I. M. Roitt, J. Brostoff, and D. K. Male, Eds.), Gower Medical Publishing, London, pp. 18.1-18.16 (1985).
3. Cappuccini, F., Yamamoto, R. S., DiSaia, P. J., Grosen, E. A., Gatanaga, M., Lucci, J. A., Ininns, E. K., Gatanaga, T., and Granger, G. A. Identification of tumor necrosis factor and lymphotoxin bloking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer, Lymphokine Cytokine Res. 10, 225-231 (1991).
4. Badger, A., Oh, S., and Moolten, F. Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody dependent cytotoxicity, Cancer Res. 41, 1133-1139 (1981).
5. Berek, J. S., Bast, R. C., Lichtensteint, A., Hacker, N. F., Spina, C. A., Lagasse, L. D., Knapp, R. C., and Zighelboim, J. Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer, Obstet. Gynecol. 64, 708-714 (1984).
6. Granger, G., Gatanaga, T., Burger, R., Grosen, E., and DiSaia, P. TNF, LT, and IL-1 natural inhibitors (soluble receptors and receptor antagonists) in women with ovarian cancer, in Ovarian Cancer 3 (F. Sharp, W. P. Mason, T. Blackett, and J. Berek, Eds.), Chapman & Hall, London, pp. 115-119 (1995).
7. Gotlieb, W. H., Abrams, J. S., Watson, J. M., Velu, T. J., Berek, J. S., and Martinez-Maza, O. Presence of IL-10 in the ascites of patients with ovarian and other intra-abdominal cancers, Cytokine 4, 385-390 (1992).
8. Hirte, H., and Clark, D. A. Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor β as a suppressive factor, Cancer Immunol. Immunother. 32, 296-302 (1991).
9. Berek, J. S., and Martinez-Maza, O. Molecular and biologic factors in the pathogenesis of ovarian cancer, J. Reprod. Med. 39, 241-248 (1994).
10. Massague, J. The transforming growth factor-β family, Annu. Rev. Cell Biol. 6, 597-624 (1990).
11. Berchuck, A., Rodriguez, G., Olt, G., Whitaker, R., Boente, M. P., Arrick, B. A., Clarke-Pearson, D. L., and Bast, R. C. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β, Am. J. Obstet. Gyn. 166, 676-684 (1992).
12. De Martin, R., Haendler, B., Hofer-Warbinex, Gaugitsch, H., Wrann, M., Schlusenere, H., Seifert, J. M., Bodmer, S., Fontana, A., and Hofer, E. Complementary DNA for human glioblastoma-derived T cell suppressor factor β, a novel member of the transforming growth factor-β family, EMBO J. 6, 3673-3677 (1987).
13. 2: Production by a prostatic adenocarcinoma cell line, purification and initial characterization, Biochemistry 26, 2406-2410 (1987).
14. Derynck, R., Jarret, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B., and Goeddel, D. V. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells, Nature 316, 701-715 (1985).
15. Wakefield, L. M., and Sporn, M. B. Suppression of carcinogenesis: A role for TGF-β and related molecules in prevention of cancer, in Tumor Suppressor Genes (G. Klein, Ed.), Dekker, New York, pp. 217-243 (1990).
16. Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X-F., Shimizu, J., Fujiwara, H., and Hamaoka, T. Transforming growth factor-β induced inhibition of T cell function, J. Immunol. 146, 1077-1082 (1991).
17. + T and NK cells, J. Exp. Med. 180, 1937-1942 (1994).
18. Pardoll, D. M. Paracrine cytokine adjuvants in cancer immunotherapy, Annu. Rev. Immunol. 13, 399-415 (1995).
19. 1 cDNA escapes immune surveillance, Proc. Natl. Acad. Sci. USA 87, 1486-1490 (1990).
20. 2 antisense gene modified tumor cells eradicates intracranial gliomas, Proc. Am. Assoc. Cancer Res. (1995) [abstract].
21. Dorigo, O., Shawler, D. L., Roiston, I., Sobol, R. E., and Fakhray, H. Transforming growth factor beta (TGF-β) inhibits effect of IL-2 gene therapy in TGF-β producing tumors, Proc. Am. Assoc. Cancer Res. (1995) [abstract].
22. McAdam, A. J., Felcher, A., Woods, M. L., Pulaski, B. A., Hutter, E. K., Frelinger, J. G., and Lord, E. M. Transfection of transforming growth factor-β producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes, J. Immunother. 15, 155-164 (1994).
23. Santin, A. D., Ioli, G. R., Hiserodt, J. C., Rose, G. S., Graf, M. R., Tocco, L. M., Lander, J. K., Eck, L. M., DiSaia, P. J., Pecorelli, S., and Granger, G. A. Development and characterization of an IL-4 secreting human ovarian carcinoma cell line, Gynecol. Oncol. 58, 230-239 (1995).
24. Santin, A. D., Ioli, G. R., Hiserodt, J. C., Manetta, A., DiSaia, P. J., Pecorelli, S., and Granger, G. A. Development and characterization of an IL-2 transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules, Am. J. Obstet. Gynecol. 174, 633-640 (1996).
25. Vanky, F., Stuber, G., Rostein, S., and Klein, E. Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: Stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen negative tumor cells, Cancer Immunol. Immunother. 28, 17-21 (1989).
26. Anichini, A., Mortarini, R., Alberti, S., Mantovani, A., and Parmiani, G. T-cell-receptor engagment and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis, Int. J. Cancer 53, 994-1001 (1993).
27. Hareyama, M., Imai, K., Kubo, K., Takahashi, H., Koshiba, H., Hinoda, Y., Shidou, M., Oouchi, A., Yachi, A., and Kazuo, M. Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells, Cancer 67, 2269-2274 (1991).
28. b in B16 melanoma cells, Cancer Res. 53, 1952-1955 (1993).